Ami Drugs

Vadodara, India Founded: 1997 • Age: 29 yrs
Produces high-quality drug intermediates, APIs, and specialty chemicals.

About Ami Drugs

Ami Drugs is a Healthcare company based in Vadodara (India) founded in 1997. It produces high-quality drug intermediates, APIs, and specialty chemicals. It operates on a B2B model. The company has 1,247 employees. Its Indian entity Ami Drugs And Speciality Chemicals Private Limited reported revenue of β‚Ή99.4 Lakh. Its focus areas include Pharmaceuticals, Chemical Manufacturing, Drug Intermediates and APIs and Specialty Chemicals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Ami Drugs, founded in 1997 in Vadodara, India, focuses on producing pharmaceutical products, chemical manufacturing, drug intermediates, and apis and specialty chemicals. Produces high-quality drug intermediates, APIs, and specialty chemicals. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Key Metrics
  • Annual Revenue
    ₹99.4 Lakh

    FY 2021 · -94% YoY

  • Net Profit
    ₹12.8 Lakh

    FY 2021 · 13% margin

  • EBITDA
    -₹4.4 Lakh

    FY 2021 · -4% margin

  • Employee Count
    1,247

Board of directors of Ami Drugs And Speciality Chemicals Private Limited (Ami Drugs)

Ami Drugs And Speciality Chemicals Private Limited is the primary company behind Ami Drugs. The boards of the 2 registered companies of Ami Drugs currently have 4 directors; the longest-serving is Girishkumar Limbabhai Chovatia, appointed in 2002. 31 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Girishkumar Limbabhai Chovatia
DIN 00907321
Managing Director24 Dec 200223 yrs 10 moAmi Lifesciences Pvt Ltd, Ami Drugs And Speciality Chemicals Private Limited
Ameeshi Girishkumar Chovatia
DIN 07591778
Director21 Dec 20223 yrs 10 moAmi Lifesciences Pvt Ltd, Ami Drugs And Speciality Chemicals Private Limited
Kiranben Girishbhai Chovatia
DIN 00803912
Director24 Jan 20242 yrs 9 moAmi Lifesciences Pvt Ltd, Ami Drugs And Speciality Chemicals Private Limited
Keshav Deo
DIN 07767679
Whole-time director27 Jun 20251 yr 4 moAmi Lifesciences Pvt Ltd

Financials of Ami Drugs

Figures of Ami Drugs And Speciality Chemicals Private Limited, the primary company behind Ami Drugs, for FY 2021. Revenue was ₹99.4 Lakh (-94% year on year). Net profit was ₹12.8 Lakh (13% margin). EBITDA was -₹4.4 Lakh (-4% margin). Revenue has grown at a compounded annual rate of -44% over three years and +6% over five years.

  • ₹99.4 LakhRevenue · FY 2021 · -94% YoY
  • ₹12.8 LakhNet profit · 13% margin
  • -₹4.4 LakhEBITDA · -4% margin
  • ₹15 LakhPaid-up capital
  • -44%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ami Drugs And Speciality Chemicals Private Limited are on its company page.

Premium access

Detailed financial statements for Ami Drugs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Ami Drugs

Ami Drugs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Ami Drugs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ami Drugs

Websites that share an audience with Ami Drugs (amidrugs.com).

Similar websites

Websites whose visitors overlap most with Ami Drugs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
acsdobfar.it
100%
2.6K#5,123,276View details
cedarburgpharma.com
94%
View details
polydex.com
94%
View details
aitanchem.com
aitanchem.com
94%
–
argosi.com.cn
argosi.com.cn
94%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for Ami Drugs

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ami Drugs

Premium access

Complete news archive for Ami Drugs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ami Drugs

Ami Drugs was founded in 1997.

Ami Drugs is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Ami Drugs has 1,247 employees.

The primary company behind Ami Drugs, Ami Drugs And Speciality Chemicals Private Limited, reported revenue of β‚Ή99.4 Lakh for FY 2021, down 94% year on year.

Ami Drugs, founded in 1997 in Vadodara, India, focuses on producing pharmaceutical products, chemical manufacturing, drug intermediates, and apis and specialty chemicals. Produces high-quality drug intermediates, APIs, and specialty chemicals. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Ami Drugs's top competitors include Laurus Labs, Symbiotec and SeQuent.

Ami Drugs is associated with 2 legal entities: Ami Drugs And Speciality Chemicals Private Limited, Ami Lifesciences Pvt Ltd.

The legal entities of Ami Drugs currently have 6 directors, including Kiranben Girishbhai Chovatia, Girishkumar Limbabhai Chovatia, Ameeshi Girishkumar Chovatia and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available